{"id": "conv1003_2-snip3", "displayed_text": "<span class=\"blueText\"><b>Patient</b>: Mmm, hmm.</span> <span class=\"redText\"><b>Doctor</b>: Then, I will be able to space it further and further apart.</span> <span class=\"blueText\"><b>Patient</b>: Okay.</span> <span class=\"redText\"><b>Doctor</b>: But the first two or three months are going to be somewhat critical.</span> <span class=\"blueText\"><b>Patient</b>: The same what we did with the Casodex?</span> <span class=\"redText\"><b>Doctor</b>: Yeah.</span> <span class=\"blueText\"><b>Patient</b>: Okay.</span> <span class=\"redText\"><b>Doctor</b>: Yeah. Okay?</span> <span class=\"blueText\"><b>Patient</b>: Alright.</span> <span class=\"redText\"><b>Doctor</b>: Alright.</span> <span class=\"blueText\"><b>Patient</b>: No problem.</span> <span class=\"redText\"><b>Doctor</b>: But, I cannot be putting you on medications and then leaving you with whatever you\u2019re dealing with. Okay. Just like that.</span>", "label_annotations": {"select_appropriateness": {"pos_empathetic": "slightly", "pos_info": "moderately", "pos_communicator": "moderately", "pos_partnership": "not at all", "pos_agency": "slightly", "pos_support": "slightly", "pos_competence": "slightly", "pos_respect": "slightly", "pos_warm": "not at all"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 27s "}}
{"id": "conv1054_1-snip5", "displayed_text": "<span class=\"blueText\"><b>Patient</b>: But that\u2019s a pretty significant consideration.</span> <span class=\"redText\"><b>Doctor</b>: Yes oh absolutely and you know you have the exact indication for requiring Xtandi now. My concern is is it worth it because the Xtandi really did take us too far in terms of giving you control from the cancer. So honestly for the Lynparza I would really push for getting the Lynparza\u2026</span> <span class=\"blueText\"><b>Patient</b>: The Lynparza is the uh inhibitor?</span> <span class=\"redText\"><b>Doctor</b>: Is the pills. The PARP inhibitor. Yes. For the BRCA mutation.</span> <span class=\"blueText\"><b>Patient</b>: And without the Xtandi?</span> <span class=\"redText\"><b>Doctor</b>: Correct.</span> <span class=\"blueText\"><b>Patient</b>: So you would just give up on the Xtandi and just go with the PARP inhibitor?</span> <span class=\"redText\"><b>Doctor</b>: And you know if we were going to do the Xtandi base treatment still then we would have to \u2013 I would say we need to combine it with something else and that something else could be the BET1 inhibitor.</span> <span class=\"blueText\"><b>Patient</b>: Is there a third option you said?</span> <span class=\"redText\"><b>Doctor</b>: Well the third option is going to chemotherapy. That is definitely an option. I\u2019m not favoring that right off the bat just now. Okay.</span> <span class=\"blueText\"><b>Patient</b>: We would do that as a last resort?</span> <span class=\"redText\"><b>Doctor</b>: Well yeah. I mean not quite last resort. I\u2019m not sure I want to wait (nervous laughter)</span>", "label_annotations": {"select_appropriateness": {"pos_empathetic": "moderately", "pos_info": "slightly", "pos_communicator": "moderately", "pos_partnership": "slightly", "pos_agency": "moderately", "pos_support": "moderately", "pos_competence": "slightly", "pos_respect": "slightly", "pos_warm": "slightly"}}, "span_annotations": {}, "behavioral_data": {"time_string": "Time spent: 0d 0h 0m 56s "}}
